CJC-1295 with DAC is studied for its ability to bind to albumin, extending its half-life and promoting prolonged stimulation of growth hormone and IGF-1 pathways. In animal models, this sustained activity supports consistent endocrine signaling compared to shorter-acting peptides.
Supporting Study: Teichman, S. L., et al. (2006). “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I by CJC-1295 in animal models.” Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. Findings: Preclinical data demonstrated extended GH and IGF-1 elevation due to DAC binding, supporting prolonged biological activity.